LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
MCF 10A NU7441
0.04
uM
LJP5
 72
hr
 513 10965 10362 1.0578 1.0258
MCF 10A Linifanib
0.37
uM
LJP6
 72
hr
 513 10979 10473 1.0485 1.0218
MCF 10A PLX-4720
0.12
uM
LJP5
 72
hr
 513 10983 10362 1.0602 1.0270
MCF 10A Imatinib
10
uM
LJP6
 72
hr
 513 11029 10473 1.0531 1.0238
MCF 10A HG-6-64-01
0.04
uM
LJP6
 72
hr
 513 11110 10473 1.0608 1.0273
MCF 10A Linifanib
0.12
uM
LJP6
 72
hr
 513 11112 10473 1.0611 1.0274
MCF 10A KIN001-043
0.04
uM
LJP6
 72
hr
 513 11127 10473 1.0625 1.0279
MCF 10A PLX-4720
0.37
uM
LJP5
 72
hr
 513 11131 10362 1.0743 1.0333
MCF 10A Foretinib
0.04
uM
LJP5
 72
hr
 513 11133 10362 1.0743 1.0333
MCF 10A Imatinib
3.33
uM
LJP6
 72
hr
 513 11182 10473 1.0679 1.0302
MCF 10A PLX-4720
1.11
uM
LJP5
 72
hr
 513 11521 10362 1.1122 1.0495
MCF 10A Linifanib
0.04
uM
LJP6
 72
hr
 513 11575 10473 1.1054 1.0465
MCF 10A Celastrol
0.04
uM
LJP6
 72
hr
 513 11579 10473 1.1058 1.0464
MCF 10A Sorafenib
0.04
uM
LJP6
 72
hr
 513 11587 10473 1.1063 1.0468
MCF 10A Celastrol
0.12
uM
LJP6
 72
hr
 513 11759 10473 1.1230 1.0538